Miller Vincent A. 4
4 · Revolution Medicines, Inc. · Filed Sep 25, 2020
Insider Transaction Report
Form 4
Miller Vincent A.
Director
Transactions
- Sale
Common Stock
2020-09-23$34.02/sh−500$17,010→ 32,133 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $34.00 to $34.0650, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,808 Restricted Stock Units.